Catalyst Pharmaceuticals (CPRX) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.46% |
| Dec 31, 2025 | -38.28% |
| Sep 30, 2025 | -40.26% |
| Jun 30, 2025 | -41.51% |
| Mar 31, 2025 | -41.67% |
| Dec 31, 2024 | -40.50% |
| Sep 30, 2024 | -42.03% |
| Jun 30, 2024 | -44.36% |
| Mar 31, 2024 | -46.73% |
| Dec 31, 2023 | -20.81% |
| Sep 30, 2023 | -14.43% |
| Jun 30, 2023 | -21.18% |
| Mar 31, 2023 | -13.72% |
| Dec 31, 2022 | -28.85% |
| Sep 30, 2022 | -49.84% |
| Jun 30, 2022 | -44.43% |
| Mar 31, 2022 | -40.19% |
| Dec 31, 2021 | -36.47% |
| Sep 30, 2021 | -57.20% |
| Jun 30, 2021 | -27.96% |
| Mar 31, 2021 | -40.75% |
| Dec 31, 2020 | -34.43% |
| Sep 30, 2020 | -28.37% |
| Jun 30, 2020 | -22.96% |
| Mar 31, 2020 | -17.70% |
| Dec 31, 2019 | -21.59% |
| Sep 30, 2019 | -15.20% |
| Jun 30, 2019 | -26.48% |
| Mar 31, 2019 | -56.99% |
| Dec 31, 2018 | -22.11% |
| Sep 30, 2018 | -21.14% |
| Jun 30, 2018 | -56.18% |
| Mar 31, 2018 | -160.80% |
| Dec 31, 2017 | -56.62% |
| Sep 30, 2017 | -23.14% |
| Jun 30, 2017 | -36.13% |
| Mar 31, 2017 | -50.55% |
| Dec 31, 2016 | -46.30% |
| Sep 30, 2016 | -34.38% |
| Jun 30, 2016 | -52.94% |
| Mar 31, 2016 | -30.43% |
| Dec 31, 2015 | -42.31% |
| Sep 30, 2015 | -42.31% |